These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 10360447
1. Predictive value of prostate-specific antigen, tumour stage and tumour grade for the outcome of bone scintigraphy in patients with newly diagnosed prostate cancer. Rydh A, Tomic R, Tavelin B, Hietala SO, Damber JE. Scand J Urol Nephrol; 1999 Apr; 33(2):89-93. PubMed ID: 10360447 [Abstract] [Full Text] [Related]
2. [Bone scintigraphy findings in patients with recently diagnosed adenocarcinoma of the prostate: relationship with prostate specific antigen levels]. Ortega A, Alonso JC, Suárez M, Domínguez P, Almoguera I, Bittini A, Gómez A, Martínez L, Herranz F, Pérez-Vázquez JM. Rev Esp Med Nucl; 2000 Oct; 19(6):409-15. PubMed ID: 11060270 [Abstract] [Full Text] [Related]
3. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort. KandaSwamy GV, Bennett A, Narahari K, Hughes O, Rees J, Kynaston H. BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247 [Abstract] [Full Text] [Related]
5. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer. Rudoni M, Antonini G, Favro M, Baroli A, Brambilla M, Cardani G, Ciardi L, Sacchetti GM, Inglese E. Eur J Nucl Med; 1995 Mar; 22(3):207-11. PubMed ID: 7540551 [Abstract] [Full Text] [Related]
6. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate. Bruwer G, Heyns CF, Allen FJ. Eur Urol; 1999 Mar; 35(3):223-7. PubMed ID: 10072624 [Abstract] [Full Text] [Related]
14. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Kosuda S, Yoshimura I, Aizawa T, Koizumi K, Akakura K, Kuyama J, Ichihara K, Yonese J, Koizumi M, Nakashima J, Fujii H. Cancer; 2002 Feb 15; 94(4):964-72. PubMed ID: 11920464 [Abstract] [Full Text] [Related]
17. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer. Wolff JM, Bares R, Jung PK, Buell U, Jakse G. Urol Int; 1996 Feb 15; 56(3):169-73. PubMed ID: 8860738 [Abstract] [Full Text] [Related]
20. [Is it possible to do without bone gammagraphy in the staging of prostatic cancer?]. Ruiz de la Roja JC, Llorente Abarca C, Romero Cagigal I, Páez Borda A, Fernández González I, Martín Osés E, Berenguer Sánchez A. Actas Urol Esp; 1995 Feb 15; 19(2):123-7. PubMed ID: 7539572 [Abstract] [Full Text] [Related] Page: [Next] [New Search]